Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
15.19
+0.68 (4.69%)
At close: Oct 13, 2025, 4:00 PM EDT
15.30
+0.11 (0.72%)
After-hours: Oct 13, 2025, 6:01 PM EDT
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,589,248
Market Cap
55.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | -9 | -50.00% |
| Dec 31, 2019 | 18 | -1 | -5.26% |
| Dec 31, 2018 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QNTM News
- 4 days ago - Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM - Business Wire
- 4 days ago - QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm - Business Wire
- 5 days ago - Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock - GlobeNewsWire
- 6 days ago - Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View - Accesswire
- 10 days ago - Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case - GlobeNewsWire
- 11 days ago - Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial - GlobeNewsWire
- 12 days ago - Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials - GlobeNewsWire
- 14 days ago - Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders - GlobeNewsWire